Propanc Biopharma Announces Plans To Start Phase 1b First-In-Human Study Of PRP In February 2027, Enrolling Up To 50 Patients With Advanced Solid Tumors In Australia; Says Ethics Submission Planned For November 2026

Loading news article.

Propanc Biopharma Announces Plans To Start Phase 1b First-In-Human Study Of PRP In February 2027, Enrolling Up To 50 Patients With Advanced Solid Tumors In Australia; Says Ethics Submission Planned For November 2026 | WAPE

Propanc Biopharma Announces Plans To Start Phase 1b First-In-Human Study Of PRP In February 2027, Enrolling Up To 50 Patients With Advanced Solid Tumors In Australia; Says Ethics Submission Planned For November 2026

Article summary

Related companies

Comments —